Tenders

GLO-BNHL: A Global Study of Novel Agents in Paediatric and Adolescent Relapsed and Refractory B-cell non-Hodgkin Lymphoma.

Closed

Deadline

Expired

June 30, 2023

Contract Details

Original Tender Description

The GLO-BNHL trial (sponsored by the University of Birmingham) is a platform study which is funded by industry collaborators and Cancer Research UK. The trial is required to have a suitably compliant clinical trial database (electronic data capture (EDC) system) that is active and ready for use by September 2022. Funding is provided to support the trial to be compliant with additional regulations (International Conference on Harmonization, the Food and Drug Administration (FDA) and European Medicines Agency (EMA) standards - specifically 21 CFR Part 11 guidance.

Risk Analysis

Please log in to use risk analysis.

Win Strategy

Please log in to access winning strategy recommendations.

Competitors

Upgrade to see which companies are likely to bid on this tender, based on historical procurement data.

Requirements & Qualifications

AI requirements analysis not yet available for this tender.

Requirements will be generated automatically when tender documents are processed.

Basic Requirements

Company registration in EU required
Proven track record in similar projects
Financial stability documentation

Documents

No processed documents available for this tender.

Documents will appear here once they are downloaded and analyzed.

Analysis Pending

Quality analysis for this tender is being processed. Please check back shortly.

AI Copilot

Hello! I'm your AI assistant for this tender. I can help you understand requirements, deadlines, eligibility criteria, and provide strategic insights.

What are the main requirements?

When is the deadline?

Who is eligible to bid?

No credit card required